Skip to main content
. 2017 Sep;9(9):3105–3113. doi: 10.21037/jtd.2017.08.11

Table 1. Patients underwent RATS for complex procedure.

Patient No./gender/age Diagnosis Reason to use RATS Operative method *Console time Operative time Drain tube duration (d) Hospital stay (d) Morbidity/mortality
1/M/31 Lung pleomorphic carcinoma s/p CCRT Difficult dissection LUL lobectomy 327 387 4 6 No
2/M/75 Lung adenocarcinoma, bronchiectasis Difficult dissection RLL lobectomy 280 340 8 25 Pneumonia
3/M/44 Lung SCC pericardium invasion s/p CCRT Difficult dissection LUL lobectomy, partial pericardiectomy 480 600 6 8 No
4/M/74 Lung adenocarcinoma, old TB Difficult dissection RUL lobectomy 480 540 8 10 No
5/F/65 Lung adenocarcinoma s/p chemotherapy Difficult dissection RUL lobectomy 240 300 4 7 No
6/M/67 Thymic carcinoma, 8.0×5.5×2.8 cm Huge tumor Thymothymectomy 110 220 5 7 No
7/F/61 Lung adenocarcinoma, locally advanced Difficult dissection, complex suture RUL sleeve lobectomy 480 540 6 8 No
8/M/72 Lung adenocarcinoma, locally advanced Difficult dissection LLL lobectomy Conversion 300 14 17 Prolonged air leak
9/M/58 Liposarcoma, pericardium invasion, 9×8×6 cm Difficult dissection, huge tumor Tumor excision with pericardiectomy 200 418 5 12 No
10/F/72 Lung adenocarcinoma, locally advanced Difficult dissection Left pneumonectomy 145 200 15 33 Mortality
11/F/60 Thyroid papillary carcinoma with lung and mediastinum metastases Difficult dissection, complex suture RLL B6 segmentectomy, multiple wedge/tumor enucleation 420 480 4 10 No
12/M/75 Lung adenocarcinoma, locally advanced Difficult dissection LUL lobectomy Conversion 540 17 20 Arrhythmia, persistent effusion
13/M/85 Pancoast tumor, locally advanced Difficult dissection Tumor excision with RUL wedge resection 112 184 7 11 No
14/M/58 Liposarcoma upper mediastinum and thoracic inlet Difficult dissection Tumor excision 300 600 7 9 No
15/M/67 Lung cancer, right upper lobe extending to RML Difficult dissection RUL sleeve lobectomy Conversion 476 16 23 Pneumonia
16/F/47 Colon cancer metastasis Complex suture Multiple wedge/tumor enucleation 284 360 5 6 No
17/M/62 Thymoma, type AB 8.3×7.6×3.4 cm Huge tumor Thymothymectomy 180 274 3 5 No
18/F/63 Lung adenocarcinoma, N2 Difficult dissection, complex suture RUL sleeve lobectomy with B6 segmentectomy 660 758 7 9 No
19/M/74 Lung adenocarcinoma, invasion of aorta adventitia Difficult dissection LUL lobectomy 265 300 7 9 No
20/M/43 Lung SCC Complex suture RUL lobectomy with bronchoplasty 200 289 3 4 No
21/M/62 Thymic cancer s/p chemotherapy Difficult dissection Tumor and LN excision 230 274 3 5 No
22/M/69 Pleomorphic carcinoma s/p neoadjuvant chemotherapy Difficult dissection, complex suture RUL sleeve lobectomy 510 598 7 12 No
23/M/35 Esophageal leiomyoma 5.8×4.4×3.9 cm Complex suture Tumor excision, repair esophageal laceration 120 186 6 8 No
24/F/60 Lung adenocarcinoma s/p chemotherapy N2 Difficult dissection LUL lobectomy 400 540 12 34 Pulmonary embolism
25/F/24 Castleman’s disease, 9.4×4.5×4.3 cm Huge tumor Tumor excision 85 180 3 4 No
26/M/32 Pancoast tumor s/p CCRT 8.5×5.5×4.0 cm Difficult dissection, huge tumor Tumor excision with RUL wedge resection 660 768 20 24 Hemothorax
27/F/42 Lung adenocarcinoma Complex suture RUL lobectomy with bronchoplasty 178 227 3 5 No
28/F/36 Invasive thymoma, type B1 11.5×8.5×2.6 cm Huge tumor Thymothymectomy 156 204 7 9 No
29/F/55 Lung carcinoid Difficult dissection, complex suture LUL sleeve lobectomy 510 600 4 7 No
30/M/45 Mediastinal atypical carcinoid Huge tumor, complex suture Tumor excision with thymectomy 224 284 4 5 No

*, Console time is the overall duration of time the surgeon spent using the robotic system during the operation. RATS, robot-assisted thoracoscopic surgery; CCRT, Concurrent chemoradiation therapy; LUL, left upper lobe; RUL, right upper lobe; SCC, squamous cell carcinoma; TB, tuberculosis; RML, right middle lobe; RLL, right lower lobe; LLL, left lower lobe.